Most CML patients express the typical e13a2 (b2a2) or e14a2 (b3a2) BCR-ABL1 transcripts corresponding to the major breakpoint cluster region (M-BCR). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.